Clinical Trials Logo

Digestive System Neoplasms clinical trials

View clinical trials related to Digestive System Neoplasms.

Filter by:

NCT ID: NCT02221700 Active, not recruiting - Clinical trials for Peripheral Neuropathy

Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies

Start date: April 9, 2015
Phase: N/A
Study type: Interventional

This clinical trial studies massage therapy in reducing chemotherapy-induced nerve problems (peripheral neuropathy) that may cause pain, numbness, tingling, swelling, or muscle weakness in different parts of the body in patients with gastrointestinal or breast malignancies. Massage therapy may help reduce chemotherapy-induced peripheral neuropathy symptoms and improve quality of life.

NCT ID: NCT02215837 Active, not recruiting - Gastric Cancer Clinical Trials

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

Start date: August 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of chemotherapy combined with autologous tumor Lysate-pulsed dendritic with cytokine-induced killer cell (Ag-D-CIK) for gastric cancer.

NCT ID: NCT02208804 Recruiting - Clinical trials for Colorectal Neoplasms

Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization

SIM
Start date: November 2014
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of the SIM trial is to investigate whether using the Surefire Infusion System during holmium-166 radioembolization increases the posttreatment tumor to non-tumor activity concentration ratio, compared with using a standard end-hole microcatheter.

NCT ID: NCT02202928 Active, not recruiting - Colorectal Cancer Clinical Trials

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Start date: July 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of autologous tumor lysate-pulsed dendritic and cytokine-induced killer cells (DC-CIK) for colorectal cancer (CRC).

NCT ID: NCT02196935 Recruiting - Pancreatitis Clinical Trials

Los Angeles Prospective GI Biliary and EUS Series

Start date: September 2010
Phase:
Study type: Observational

Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound are increasingly being used to manage complex disease of the bile duct, pancreas and cancer. Gastroenterology patients at the Los Angeles County Hospital presents a unique and diverse patient population. Our aim is to study the biochemical, radiographic, and clinical predictors of bile duct stones. Exploratory aims include the study of the management of cholangitis, bile leaks, GI cancer diagnosis and management, and the management of pancreaticobiliary problems in the underserved. All patients managed by EUS or ERCP at the LA County & USC University Hospitals will be enrolled in the databaseThe timing, clinical presentation, and objective details of patient presentation are recorded prospectively. Additionally the results of the subsequent ERCP and EUS procedures. Subsequent, clinical course and pathology will also be recorded.

NCT ID: NCT02192333 Completed - Depression Clinical Trials

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Start date: August 3, 2015
Phase: N/A
Study type: Interventional

This randomized clinical trial studies survivorship care in reducing symptoms in young adult cancer survivors. Survivorship care programs that identify the needs of young adult cancer survivors and ways to support them through the years after treatment may help reduce symptoms, such as pain, fatigue, sleep disturbance, depression, and distress, in young adult cancer survivors.

NCT ID: NCT02169388 Recruiting - Colorectal Cancer Clinical Trials

Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy

Start date: June 2014
Phase: Phase 1
Study type: Interventional

Probiotics modulate the gut microflora and immune status in CRC,which can reduce the side effects of chemotherapy such as diarrhea,infection,neutropenia etc.

NCT ID: NCT02148159 Completed - Clinical trials for Malignant Neoplasm of Gastrointestinal Tract

Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer

Start date: October 2014
Phase: N/A
Study type: Interventional

Patients with cancer often experience appetite loss and weight loss unintentionally. Rapid weight loss negatively impact on physical functioning, quality of life, and overall survival. Patients will be randomly assigned into two groups. An intervention with acupuncture may slow down or stop the progression of cancer-related anorexia and weight loss.

NCT ID: NCT02080702 Terminated - Clinical trials for Gastrointestinal Neoplasms

An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract

PROMEGAT
Start date: August 2014
Phase:
Study type: Observational

The aim of this non-interventional study is to evaluate the efficacy of a monofilament, mid-term absorbable suture material (Monosyn®) for anastomosis performed in the gastrointestinal tract using the frequency of anastomosis leakage as a primary parameter. Postoperative complication rate, length of hospital stay, costs, time to perform the anastomosis and handling will serve as secondary endpoints. The question is addressed, whether a monofilament suture material is as effective as a braided suture material for anastomosis construction within the gastrointestinal tract.

NCT ID: NCT02056015 Completed - Clinical trials for Imaging of Solid Gastrointestinal Tumors

A Phase I Study of MLN6907 in Patients With Metastatic Colorectal

Start date: June 2015
Phase: Phase 1
Study type: Interventional

This study is a first-in-human (FIH), single-dose, open-label, phase 1 study designed to assess the safety, pharmacokinetics (PK), distribution, and radiation dosimetry of [68Ga]MLN6907 after a single intravenous (IV) administration. Patients with Metastatic Colorectal Carcinoma who are scheduled for resection of liver metastases as part of their treatment plan will be eligible for enrollment.